IMPORTANT: PLEASE READ CAREFULLY BEFORE SIGNING. SIGNIFICANT REPRESENTATIONS ARE CALLED FOR HEREIN. SUBSCRIPTION AGREEMENT and LETTER OF INVESTMENT INTENTSubscription Agreement • February 4th, 2010 • Omni Bio Pharmaceutical, Inc. • Biological products, (no disgnostic substances) • Colorado
The undersigned (the "Subscriber") hereby tenders this subscription for the purchase of units (“Units” or “Securities”) issued by Omni Bio Pharmaceutical, Inc. (the “Company”). Each Unit consists of one share of the common stock of the Company (“Common Stock”), and one warrant to purchase a share of the common stock of the Company at an exercise price of $3.75 per share (a “Warrant”). The Units are being offered at a price of $2.50 per Unit (the “Offering”). By execution below, the Subscriber acknowledges that the Company is relying upon the accuracy and completeness of the representations and warranties contained herein in complying with its obligations under applicable securities laws.
